Bettina M. Cockroft

Insider Reports History

Location
C/O Annexon, Inc., 180 Kimball Way, Suite 200, South San Francisco, CA
Signature
/s/ Christopher Downs, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Bettina M. Cockroft:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Annexon, Inc. Director Stock Option (Right to Buy) 55K Jun 5, 2025 Direct
CNS Pharmaceuticals, Inc. Director Option to purchase common stock 1.52K Nov 17, 2025 Direct

Insider Reports Filed by Bettina M. Cockroft

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CNSP CNS Pharmaceuticals, Inc. Nov 17, 2025 1 $0 4 Nov 19, 2025 Director
ANNX Annexon, Inc. Jun 5, 2025 1 $0 4 Jun 9, 2025 Director
ANNX Annexon, Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
CNSP CNS Pharmaceuticals, Inc. Apr 8, 2024 2 $0 4 Apr 10, 2024 Director
CNSP CNS Pharmaceuticals, Inc. Sep 21, 2023 1 $0 4 Sep 25, 2023 Director
CNSP CNS Pharmaceuticals, Inc. Sep 14, 2023 2 $0 4/A Oct 12, 2023 Director
ANNX Annexon, Inc. Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
CNSP CNS Pharmaceuticals, Inc. May 5, 2023 1 $0 4/A Aug 10, 2023 Director
CNSP CNS Pharmaceuticals, Inc. May 3, 2023 0 $0 3 May 9, 2023 Director
ANNX Annexon, Inc. Jun 9, 2022 1 $0 4 Jun 13, 2022 Director
ANNX Annexon, Inc. Jan 19, 2022 1 $0 4 Jan 20, 2022 Director
ANNX Annexon, Inc. Jan 19, 2022 0 $0 3 Jan 20, 2022 Director